一、研究方向:幽門螺桿菌耐藥機制;消化道菌群與健康
二、科研成果
(一)承擔課題
(1) 抗生素通過ROS抑制mutS、mutY表達介導幽門螺桿菌耐藥機制研究(82172313),國家自然科學基金委面上項目, 55萬元, 2022-2025。
(2) 抗幽門螺桿菌試劑盒的研發(與江蘇綠葉診斷技術有限公司橫向項目),100萬元,2023-2026。
(3) SpoT(ppGpp)調控幽門螺桿菌適應抗生素壓力分子機制研究(81471991),國家自然基金面上項目,72萬,2015-2018。
(4) 壓力加重幽門螺桿菌胃炎分子機制研究(81671978),國家自然基金面上項目,70萬,2017-2020。
(5) 幽門螺桿菌SpoT基因適應INF-γ表達調控機制研究(81071313),國家自然基金面上項目,32萬,2011-2013。
(6) SpoT調控幽門螺旋桿菌氧應激嚴謹應答分子機制研究(30800037),國家自然基金青年基金,20萬,2009-2011
(二)發表論文(*:通訊作者,#:共同第一)
1、 Sun Y, Zhang M, Chen CC, Gillilland M 3rd, Sun X, El-Zaatari M, Huffnagle GB, Young VB, Zhang J, Hong SC, Chang YM, Gumucio DL, Owyang C, Kao JY*. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. Gastroenterology. 144(7):1478-87, 1487.e1-8; 2013 Jun.
2、 Xue J, Li S, Wang L, Zhao Y, Zhang L, Zheng Y, Zhang W, Chen Z, Jiang T, Sun Y*. Enhanced fatty acid biosynthesis by Sigma28 in stringent responses contributes to multidrug resistance and biofilm formation in Helicobacter pylori. Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0085024. doi: 10.1128/aac.00850-24.
3、 Xue J, Li W, Zhao Y, Wang L, Cheng P, Zhang L, Zheng Y, Zhang W, Bi Y, Chen Z, Jiang T, Sun Y. Antibiotic-induced ROS-mediated Fur allosterism contributes to Helicobacter pylori resistance by inhibiting arsR activation of mutS and mutY. Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0167923. doi: 10.1128/aac.01679-23. Epub 2024 Feb 22. PMID: 38386782; PMCID: PMC10989006..
4、 Wang D, Feng Y, Yang M, Sun H, Zhang Q, Wang R, Tong S, Su R, Jin Y, Wang Y, Lu Z, Han L, Sun, Y*. Variations in the oral microbiome and metabolome of methamphetamine users. mSystems. 2024 Jan 23;9(1):e0099123. doi: 10.1128/msystems.00991-23.
5、 Wang L, Yu Y, Tao Y, Zhao M, Zhang L, Xue J, Zhao Y, Zhan P, Sun, Y*. The Quinone-Derived Small Molecule M5N32 Is an Effective Anti-Helicobacter pylori Agent Both In Vivo and In Vitro. J Infect Dis. 2022 Dec 8;226(Suppl 5):S493-S502. doi: 10.1093/infdis/jiac401. PMID: 36478249.
6、 Li, Y., Li, W., Wang, X., Ding, C., Liu, J., Li, Y., Li, W., & Sun, Y*. (2020). High-Salt Diet-Induced Gastritis in C57BL/6 Mice is Associated with Microbial Dysbiosis and Alleviated by a Buckwheat Diet. Molecular nutrition & food research, 64(8), e1900965.
7、 Zhao, Y., Cai, Y., Chen, Z., Li, H., Xu, Z., Li, W., Jia, J., & Sun, Y*. (2021). SpoT-mediated NapA upregulation promotes oxidative stress induced Helicobacter pylori biofilm formation and confers multidrug resistance. Antimicrobial agents and chemotherapy, AAC.00152-21.
8、 Cai, Y., Wang, C., Chen, Z., Xu, Z., Li, H., Li, W., & Sun, Y*. (2020). Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux. Helicobacter, e12715.
9、 Ge, X., Cai, Y., Chen, Z., Gao, S., Geng, X., Li, Y., Li, Y., Jia, J., & Sun, Y*. (2018). Bifunctional Enzyme SpoT Is Involved in Biofilm Formation of Helicobacter pylori with Multidrug Resistance by Upregulating Efflux Pump Hp1174 (gluP). Antimicrobialagents and chemotherapy, 62(11), e00957-18.
10、 Geng, X., Li, W., Chen, Z., Gao, S., Hong, W., Ge, X., Hou, G., Hu, Z., Zhou, Y., Zeng, B., Li, W., Jia, J., & Sun, Y*. (2017). The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471. Antimicrobial agents and chemotherapy, 61(5), e02011-16
三、教學成果
1、參編第10版《醫學微生物學》;山東省精品課程骨幹成員。
2、2014年山東大學中青年教師講課比賽優秀獎。
3、作為醫學微生物系中青年教學骨幹教師參加山東大學教學與促進發展中心舉辦的教學能力提升研修班。
4、山東省微課比賽三等獎
5、全國醫學類微課比賽鼓勵獎
四、其它工作(指導本科生創新實驗)
1、指導口腔學院校長獎學金獲得者馬駟駸大學生創新實驗
2、指導口腔學院本本科生胡哲凱等大學生創新實驗,並在《oncotarget》發表文章
3、指導醫學院七年制學生趙朗等大學生創新實驗
5、指導口腔學院本科生李淑彤,榮興等獲得國家級大學生創新項目
6、指導研究生李淑彤被美國Southern California大學錄取為博士研究生